Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bio-Rad Laboratories, Inc. BIO

Full chart Compare
Set alert

Price alert · BIO

All alert types
379.99 USD +5.08 (+1.35%)

At closeNov 4, 2026, 4:15 PM EST

379.29 -0.70 -0.18%

After hours · Nov 4, 4:15 PM ET

371.85 Day range 382.00
236.73 52-week range 396.23
YTD
+25.41%
1 year
+22.20%

Financial health

Altman Z-Score

3.67 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 3
  • Return on Equity 2
  • Return on Assets 3
  • Debt / Equity 3
  • P/E 2
  • P/B 4

Valuation

P/E 10.9×
FY 2016: 207×FY 2017: 57.9×FY 2018: 19.2×FY 2019: 6.3×FY 2020: 4.6×FY 2021: 5.3×FY 2022: -3.5×FY 2023: -14.8×FY 2024: -5.0×FY 2025: 10.9×
FY 2016 5y median -3.5× FY 2025
P/S 3.2×
FY 2016: 2.6×FY 2017: 3.3×FY 2018: 3.0×FY 2019: 4.8×FY 2020: 6.8×FY 2021: 7.7×FY 2022: 4.5×FY 2023: 3.5×FY 2024: 3.6×FY 2025: 3.2×
FY 2016 5y median 3.6× FY 2025
P/B 1.1×
FY 2016: 2.1×FY 2017: 2.4×FY 2018: 1.7×FY 2019: 1.9×FY 2020: 1.8×FY 2021: 1.6×FY 2022: 1.3×FY 2023: 1.1×FY 2024: 1.4×FY 2025: 1.1×
FY 2016 5y median 1.3× FY 2025
P/FCF 22.1×
FY 2016: 72.0×FY 2017: -644×FY 2018: 44.5×FY 2019: 30.7×FY 2020: 36.4×FY 2021: 42.1×FY 2022: 156×FY 2023: 43.2×FY 2024: 34.8×FY 2025: 22.1×
FY 2016 5y median 42.1× FY 2025
EV/EBITDA 7.7×
FY 2016: 25.9×FY 2017: 26.5×FY 2018: 10.3×FY 2019: 4.6×FY 2020: 3.3×FY 2021: 4.0×FY 2022: -3.0×FY 2023: -15.9×FY 2024: -4.7×FY 2025: 7.7×
FY 2016 5y median -3.0× FY 2025
EV/Sales 3.6×
FY 2016: 2.6×FY 2017: 3.3×FY 2018: 3.0×FY 2019: 4.8×FY 2020: 6.6×FY 2021: 7.6×FY 2022: 4.8×FY 2023: 3.9×FY 2024: 4.0×FY 2025: 3.6×
FY 2016 5y median 4.0× FY 2025
FCF Yield 4.5%
FY 2016: 1.4%FY 2017: -0.2%FY 2018: 2.2%FY 2019: 3.3%FY 2020: 2.7%FY 2021: 2.4%FY 2022: 0.6%FY 2023: 2.3%FY 2024: 2.9%FY 2025: 4.5%
FY 2016 5y median 2.4% FY 2025

Profitability

Gross Margin 52.0%
FY 2016: 55.0%FY 2017: 55.0%FY 2018: 53.5%FY 2019: 54.4%FY 2020: 56.5%FY 2021: 56.1%FY 2022: 55.9%FY 2023: 53.4%FY 2024: 53.7%FY 2025: 52.0%
FY 2016 5y median 53.7% FY 2025
Operating Margin 10.5%
FY 2016: 2.6%FY 2017: 5.4%FY 2018: -4.7%FY 2019: 9.9%FY 2020: 16.6%FY 2021: 17.1%FY 2022: 17.2%FY 2023: 12.6%FY 2024: 10.5%FY 2025: 10.5%
FY 2016 5y median 12.6% FY 2025
Net Margin 29.4%
FY 2016: 1.4%FY 2017: 5.3%FY 2018: 15.8%FY 2019: 76.1%FY 2020: 149.8%FY 2021: 145.6%FY 2022: -129.5%FY 2023: -23.9%FY 2024: -71.9%FY 2025: 29.4%
FY 2016 5y median -23.9% FY 2025
ROE 10.2%
FY 2016: 1.1%FY 2017: 3.9%FY 2018: 9.0%FY 2019: 30.6%FY 2020: 38.6%FY 2021: 31.1%FY 2022: -37.7%FY 2023: -7.3%FY 2024: -28.1%FY 2025: 10.2%
FY 2016 5y median -7.3% FY 2025
ROIC 2.0%
FY 2016: 1.1%FY 2017: 3.1%FY 2018: -1.5%FY 2019: 2.4%FY 2020: 2.6%FY 2021: 2.3%FY 2022: 2.9%FY 2023: 2.1%FY 2024: 2.4%FY 2025: 2.0%
FY 2016 5y median 2.3% FY 2025
ROA 7.2%
FY 2016: 0.7%FY 2017: 2.7%FY 2018: 6.4%FY 2019: 22.0%FY 2020: 29.4%FY 2021: 23.9%FY 2022: -26.9%FY 2023: -5.2%FY 2024: -19.7%FY 2025: 7.2%
FY 2016 5y median -5.2% FY 2025

Growth (YoY)

Revenue 0.7%
FY 2016: 2.4%FY 2017: 4.4%FY 2018: 6.0%FY 2019: 0.9%FY 2020: 10.1%FY 2021: 14.8%FY 2022: -4.1%FY 2023: -4.7%FY 2024: -3.9%FY 2025: 0.7%
FY 2016 FY 2025
Operating Income 0.6%
FY 2016: -68.1%FY 2017: 119.3%FY 2018: -193.1%FY 2019: 311.4%FY 2020: 83.5%FY 2021: 18.8%FY 2022: -3.5%FY 2023: -30.0%FY 2024: -20.4%FY 2025: 0.6%
FY 2016 FY 2025
EPS (diluted) 142.6%
FY 2016: -76.3%FY 2017: 362.5%FY 2018: 193.4%FY 2019: 388.0%FY 2020: 116.6%FY 2021: 11.6%FY 2022: -186.5%FY 2023: 82.1%FY 2024: -199.5%FY 2025: 142.6%
FY 2016 FY 2025
Free Cash Flow 40.7%
FY 2016: 2.3%FY 2017: -114.8%FY 2018: 1516.4%FY 2019: 130.9%FY 2020: 32.6%FY 2021: 12.4%FY 2022: -85.0%FY 2023: 171.8%FY 2024: 22.0%FY 2025: 40.7%
FY 2016 FY 2025

Financial Health

Current Ratio 5.6×
FY 2016: 3.9×FY 2017: 3.9×FY 2018: 4.5×FY 2019: 2.4×FY 2020: 3.4×FY 2021: 2.9×FY 2022: 5.6×FY 2023: 5.8×FY 2024: 6.5×FY 2025: 5.6×
FY 2016 5y median 5.6× FY 2025
Quick Ratio 4.2×
FY 2016: 2.8×FY 2017: 2.7×FY 2018: 3.2×FY 2019: 1.8×FY 2020: 2.4×FY 2021: 2.1×FY 2022: 4.3×FY 2023: 4.3×FY 2024: 4.9×FY 2025: 4.2×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 0.2×
FY 2016: 0.2×FY 2017: 0.1×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.8×
FY 2016: -0.1×FY 2017: 0.2×FY 2018: 0.0×FY 2019: -0.0×FY 2020: -0.1×FY 2021: -0.0×FY 2022: -0.2×FY 2023: -1.5×FY 2024: -0.4×FY 2025: 0.8×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 5.5×
FY 2016: 2.3×FY 2017: 5.1×FY 2018: -4.5×FY 2019: 9.8×FY 2020: 19.3×FY 2021: 323×FY 2022: 12.7×FY 2023: 6.8×FY 2024: 5.5×FY 2025: 5.5×
FY 2016 5y median 6.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31